Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical & Medical Microbiology Volume 1 (2016), Article ID 1:IJCMM-114, 6 pages
https://doi.org/10.15344/2456-4028/2016/114
Research Article
Human Vaccines for Oncogenic Viruses and Perspectives for Tumor Antigens Induced by Virus

Giulio Tarro

President Foundation T. & L. de Beaumont Bonelli for cancer research, Naples, Italy
Chairman of the Committee on Biotechnologies and VirusSphere, WABT - UNESCO, Paris, France
Dr. Giulio Tarro, President Foundation T. & L. de Beaumont Bonelli for cancer research, Naples, Italy; E-mail: giuliotarro@gmail.com
26 August 2016; 19 November 2016; 21 November 2016
Tarro G (2016) Human Vaccines for Oncogenic Viruses and Perspectives for Tumor Antigens Induced by Virus. Int J Clin Med Microbiol 1: 114. doi: https://doi.org/10.15344/2456-4028/2016/114
© 2016 Tarro. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Tarro G (2013) Origin of the Viruses and their evolutionary History. Advanced Studies in Biology 6: 423-430 [Google Scholar]
  2. Tarro G (2016) Lights and shadows of vaccination. Journal of Vaccine Research and Development 1: 1-4 [Google Scholar]
  3. Tarro G (2014) Viral latency, molecular pathogenesis and malignancy. Global Journal of Sciences Frontier Research 14: 55-60 [Google Scholar]
  4. Roizman B, Zhou G, Du T (2011) Checkpoints in productive and latent infections with herpes simplex virus 1: conceptualization of the issues. J Neurovirol 17: 512-517 [CrossRef] [Google Scholar] [PubMed]
  5. Hayward GS, Donald JA, Arav-Boger R (2010) The role of KSHV in pathogenesis of Kaposi’s sarcoma in Viral Oncology Khalili K., Jeang K-T. (Eds), Wiley – Blackwell, Hoboken, New Jersey, USA, 377-407
  6. Chery MH, Chen OS (2010) Hepatitis B vaccine and hepatocellular carcinoma in Viral Oncology Kalili K., Jean K. T. (eds), Wiley- Blackwell Hoboken, New Jersy, Usa, 225-242
  7. Hausen HZ (2007) Infections causing human cancer. Wiley – VCH: Weinheim, Germany, pp 532 [Google Scholar]
  8. Baldwin A, Munger K (2010) Molecular events associated with human papillomavirus-induced human cancers in Viral Oncology Khalili K., Jeang K-T. (Eds), Wiley – Blackwell, Hoboken, New Jersey, USA, 23-55 [Google Scholar]
  9. Thomas M, Pim D, Banks L (2010) The role of the human papillomavirus E6 oncoprotein in malignant progression in Viral Oncology Khalili K., Jeang K-T. (Eds), Wiley – Blackwell, Hoboken, New Jersey, USA, 57-58 [Google Scholar]
  10. Feitelson MA, Reis H, Pan J, Sun B (2010) Pathogenesis of acute abd chronic hepatitis C virus infection in Viral Oncology Khalili K., Jeang K-T. (Eds), Wiley – Blackwell, Hoboken, New Jersey, USA, 243-266 [Google Scholar]
  11. Tarro G (2013) TLP sequenced and studies for its functions with targets diagnostic and therapeutic. Advanced Studies in Biology 5: 191-198 [CrossRef] [Google Scholar]
  12. Hollinshead A, McCammon JR, Yohn DS (1975) Immunogenecity of a soluble transplantation antigen from adenovirus 12 - induced tumor cells demostrated in inbred hamsters (PD-4). Can. J. Microbiol 18:1365-1369 [CrossRef] [Google Scholar] [PubMed]
  13. Tarro G, Pederzini A, Flaminio G, Maturo S (1983) Human tumor antigens inducing in vivo delayed hypersensitivity and in vitro mitogenic activity. Oncology 40: 248-254 [CrossRef] [Google Scholar] [PubMed]
  14. Tarro G (1991) Present and future of cancer immunotherapy: Sagripanti A, Gagliardi C, Carpi A, Tarro G , editors. Progress in Medicine and Surgery, Proc. Nat. Meeting, San Romano (Pisa) 13 April 1991, 181-186 ETS, Publisher, Pisa
  15. Finn OJ (2008) Cancer immunology. N Engl J Med 358: 2704-2715 [CrossRef] [Google Scholar] [PubMed]
  16. Tarro G, Esposito C (2002) Progress and new hope in the fight against cancer: novel developments in early detection of lung cancer. Int Med 10: 7-11
  17. Tarro G (2009) Tumor liberated protein from lung cancer and perspectives for immunotherapy. J Cell Physiol 221: 26-30 [CrossRef] [Google Scholar] [PubMed]
  18. Herberman RB (1997) Immunotherapy: where we are and how to proceed. In: Croce CM Doctor’s Acta, pp 14-15
  19. Benjamini E, Rennick DM (1979) Cancer immunotherapy: facts and fancy. CA Cancer J Clin 29: 362-370 [CrossRef] [Google Scholar] [PubMed]
  20. Weiss DW (1980) Tumor antigenicity and approaches to tumor immunotherapy. An outline. Curr Top Microbiol Immunol 89: 1-83 [Google Scholar] [PubMed]
  21. Prager MD, Hollinshead AC, Ribble RJ, Derr I (1973) Immunity induction by multiple methods, including soluble membrane fractions to a mouse lymphoma. J Natl Cancer Inst 51: 1607
  22. Wu F, Wu Q (2003) Corin-mediated processing of pro-atrial natriuretic peptide in human small cell lung cancer cells. Cancer Res 63: 8318-8322 [Google Scholar] [PubMed]
  23. Qi X, Jiang J, Zhu M, Wu Q (2011) Human corin isoforms with different cytoplasmic tails that alter cell surface targeting. The Journal of Biological Chemistry 286: 20963-20969 [CrossRef] [Google Scholar] [PubMed]
  24. Tarro G, Perna A, Esposito C (2005) Early diagnosis of lung cancer by detection of tumor liberated protein. J Cell Physiol 203: 1-5 [CrossRef] [Google Scholar] [PubMed]
  25. Tarro G, Esposito C, Perna A, Claudio PP, Giordano A (1998) Immunoistochemical characterization of tumor liberated particles (TLP) expression pattern in lung cancer. Anticancer Res 18: 2365-2370 [Google Scholar] [PubMed]
  26. Tarro G, Marshak DR, Perna A, Esposito C (1993) Antigenic regions of tumor liberated protein complexes and antibodies against the same. In: A. Carpi, A. Sagripanti, B. Grassi, editors. Third International Congress. Advances in Management of Malignancies. Pisa, Italy: 6/10 December 1993. Biomed & Pharmacother 47: 237-240 [CrossRef] [Google Scholar] [PubMed]
  27. Guadagni F, Graziano P, Roselli M, Mariotti S, Bernard P, et al. (2000) Differential expression of a new tumor-associated-antigen TLP during human colorectal cancer tumorigenesis. Am J Pathol 154: 993-999 [CrossRef] [Google Scholar] [PubMed]
  28. Rasi G, Sinibaldi-Vallebona P, Serafino A, Bernard P, Pierimarchi P, et al. (2000) A new human tumor-associated antigen (TLP) is naturally espressed in rat DHD-K12 colorectal tumor cells. Int J Cancer 85: 540-544 [CrossRef] [Google Scholar] [PubMed]
  29. Esposito C, Tarro G, Cuomo N, Morelli F (1997) Anti-TLP antibodies in lung cancer patients. Int Med 5: 191-194
  30. Indovina P, Marcelli E, Maranta P, Tarro G (2011) Lung cancer proteomics: recent advances in biomarker discovery. Int J Proteomics 2011: 726869 [CrossRef] [Google Scholar] [PubMed]
  31. Tarro G (1999) Tumor liberated protein (TLP): its potential for diagnosis and therapy. Anticancer Res 19: 1755-1757 [Google Scholar] [PubMed]
  32. Bernard P, Sinibaldi-Vallebona P, Rasi G, Guarino E, Guadagni F (1998) Immunisation with TLP (A new Tumor Associated Antigen) induces CTL activity in syngeneic rats. Anticancer Res 18: 4990-4994
  33. Tarro G (2000) An overview of the lung tumor liberated protein (TLP). Characterization of the genetic immunologic profile. Int Med 8: 5-8 [Google Scholar]
  34. Tarro G (2002) Characterization of a fragment containing a putative TLP cDNA sequence. Anticancer Res 22: 2693-2696 [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.